News: Eisai Breaks Ground in Research Triangle Park Expansion. …
Wednesday, November 5th, 2008Eisaibroke ground for a new pharmaceutical production and formulation R&D facility for parenteral, or intravenous, oncology treatments in Research Triangle Park. Eisai has a number of drugs in development for patients with cancer and recently entered the market through the acquisition of four oncology-related products from Ligan…
